Synthesis, Biological Evaluation and Docking Studies of Aurone Derivatives on Xanthine Oxidase Enzyme
Keywords:
Auron, xantin oksidase, dok, sintesis, biologiAbstract
Inhibition of xanthine oxidase (XO) activity is an effective therapeutic approach for the treatment of diseases such as gout and hyperuricemia. Additionally, the use of XO inhibitors can further be extended to injury treatments such as ischemic reperfusion in various organs such as heart, liver and kidney. In this study, 7 aurone compounds were synthesized and tested on XO and compared with the positive control allopurinol. Compound 5e was identified as the most potent compound and was able to inhibit half of XO activity at 33.23 μM followed by compounds 5f and 5d at 210.22 μM and 302.0 μM, respectively. Finally, molecular docking study was conducted to understand the important binding interactions of the selected aurone with the active site of XO. DOI : http://dx.doi.org./10.17576/JSKM-2018-1601-17Downloads
Published
Issue
Section
License
It is a condition of publication in the Journal that authors assign copyright to the Penerbit, Universiti Kebangsaan Malaysia, using the form available on the Copyright Assignment Form page. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning copyright, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Penerbit Universiti Kebangsaan Malaysia is notified in writing and in advance.
Our journal offers an open access articles, which is under the Creative Common license type : Attribution-NonCommercial-ShareAlike (CC BY-NC-SA)